Exact Mass: 317.0544

Exact Mass Matches: 317.0544

Found 47 metabolites which its exact mass value is equals to given mass value 317.0544, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Nilutamide

5,5-Dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)- 2,4-imidazolidinedione

C12H10F3N3O4 (317.0623)


Nilutamide is an antineoplastic hormonal agent primarily used in the treatment of prostate cancer. Nilutamide is a pure, nonsteroidal anti-androgen with affinity for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors). Consequently, Nilutamide blocks the action of androgens of adrenal and testicular origin that stimulate the growth of normal and malignant prostatic tissue. Prostate cancer is mostly androgen-dependent and can be treated with surgical or chemical castration. To date, antiandrogen monotherapy has not consistently been shown to be equivalent to castration. CONFIDENCE standard compound; INTERNAL_ID 279; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4399; ORIGINAL_PRECURSOR_SCAN_NO 4395 CONFIDENCE standard compound; INTERNAL_ID 279; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4426; ORIGINAL_PRECURSOR_SCAN_NO 4421 CONFIDENCE standard compound; INTERNAL_ID 279; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4395; ORIGINAL_PRECURSOR_SCAN_NO 4393 CONFIDENCE standard compound; INTERNAL_ID 279; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4406; ORIGINAL_PRECURSOR_SCAN_NO 4401 CONFIDENCE standard compound; INTERNAL_ID 279; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4403; ORIGINAL_PRECURSOR_SCAN_NO 4401 CONFIDENCE standard compound; INTERNAL_ID 279; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4490; ORIGINAL_PRECURSOR_SCAN_NO 4487 L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen D000970 - Antineoplastic Agents

   

N-Glycolyl-D-mannosamine 6-phosphate

N-Glycolyl-D-mannosamine 6-phosphate

C8H16NO10P (317.0512)


   

7,8-Dihydroneopterin 2,3-cyclic phosphate

7,8-dihydro-D-neopterin 2,3-cyclic phosphate

C9H12N5O6P (317.0525)


   

2,3,4-Tri-O-acetylarabinopyranosyl isothiocyanate

2,3,4-Tri-O-acetylarabinopyranosyl isothiocyanic acid

C12H15NO7S (317.0569)


   
   
   

1-{3-[(4-chlorophenyl)sulfonyl]-2-hydroxypropyl}-2-pyrrolidinone

1-{3-[(4-chlorophenyl)sulfonyl]-2-hydroxypropyl}-2-pyrrolidinone

C13H16ClNO4S (317.0489)


   
   
   
   
   

Poly(3-hexylthiophene-2,5-diyl)

Poly(3-hexylthiophene-2,5-diyl)

C13H16ClNO4S (317.0489)


   

4-Nitrophenyl 1-thio-β-D-galactopyranoside

4-Nitrophenyl 1-thio-β-D-galactopyranoside

C12H15NO7S (317.0569)


   

tert-Butyl 3-(((trifluoromethyl)sulfonyl)oxy)-2,5-dihydro-1H-pyrrole-1-carboxylate

tert-Butyl 3-(((trifluoromethyl)sulfonyl)oxy)-2,5-dihydro-1H-pyrrole-1-carboxylate

C10H14F3NO5S (317.0545)


   

2,5-DIOXOPYRROLIDIN-1-YL 7-METHOXY-2-OXO-2H-CHROMENE-3-CARBOXYLATE

2,5-DIOXOPYRROLIDIN-1-YL 7-METHOXY-2-OXO-2H-CHROMENE-3-CARBOXYLATE

C15H11NO7 (317.0535)


   

4-Nitrophenylb-D-thiomannopyranoside

4-Nitrophenylb-D-thiomannopyranoside

C12H15NO7S (317.0569)


   

2-[(2,4-dichloropyrrolo[2,3-d]pyrimidin-7-yl)methoxy]ethyl-trimethylsilane

2-[(2,4-dichloropyrrolo[2,3-d]pyrimidin-7-yl)methoxy]ethyl-trimethylsilane

C12H17Cl2N3OSi (317.0518)


   

5-(2-AMINO-4-CARBOXYPHENOXY)ISOPHTHALIC ACID

5-(2-AMINO-4-CARBOXYPHENOXY)ISOPHTHALIC ACID

C15H11NO7 (317.0535)


   

1H-Pyrrolo[2,3-b]pyridine, 1-[(4-methylphenyl)sulfonyl]-4-nitro-

1H-Pyrrolo[2,3-b]pyridine, 1-[(4-methylphenyl)sulfonyl]-4-nitro-

C14H11N3O4S (317.047)


   

Dabuzalgron

Dabuzalgron

C12H16ClN3O3S (317.0601)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist Dabuzalgron (Ro 115-1240) is an orally active and selective α-1A adrenergic receptor agonist for the treatment of urinary incontinence. Dabuzalgron protects against Doxorubicin-induced cardiotoxicity by preserving mitochondrial function[1].

   

o-nitrophenyl-1-thio-beta-d-galactopyranoside

o-nitrophenyl-1-thio-beta-d-galactopyranoside

C12H15NO7S (317.0569)


   

1-Phenethylpiperidine

1-Phenethylpiperidine

C13H20IN (317.064)


   

8-CHLORO-1-(2-FLUORO-6-METHOXYPHENYL)-3H-BENZO[C]AZEPIN-5(4H)-ONE

8-CHLORO-1-(2-FLUORO-6-METHOXYPHENYL)-3H-BENZO[C]AZEPIN-5(4H)-ONE

C17H13ClFNO2 (317.0619)


   

2-(4-chlorophenyl)7-methyl-5-oxo-2-phenyl-5H-imidazo1,2-aüpyrimidin-8(5H)-ylüacetic acid

2-(4-chlorophenyl)7-methyl-5-oxo-2-phenyl-5H-imidazo1,2-aüpyrimidin-8(5H)-ylüacetic acid

C15H12ClN3O3 (317.0567)


   

N-Cbz-4-piperidine sulfonyl chloride

N-Cbz-4-piperidine sulfonyl chloride

C13H16ClNO4S (317.0489)


   

Ethyl 6-(2-nitrophenyl)imidazo[2,1-b]thiazole-3-carboxylate

Ethyl 6-(2-nitrophenyl)imidazo[2,1-b]thiazole-3-carboxylate

C14H11N3O4S (317.047)


   

Para-nitrophenyl 1-thio-beta-d-glucopyranoside

Para-nitrophenyl 1-thio-beta-d-glucopyranoside

C12H15NO7S (317.0569)


   
   

N-(4-fluoro-1,3-benzothiazol-2-yl)-2-phenoxyacetohydrazide

N-(4-fluoro-1,3-benzothiazol-2-yl)-2-phenoxyacetohydrazide

C15H12FN3O2S (317.0634)


   

(5Z)-3-ethyl-5-[(2-methyl-2H-chromen-3-yl)methylene]-2-thioxo-thiazolidin-4-one

(5Z)-3-ethyl-5-[(2-methyl-2H-chromen-3-yl)methylene]-2-thioxo-thiazolidin-4-one

C16H15NO2S2 (317.0544)


   

N-(1,3-benzodioxol-5-yl)-5-oxo-2,3-dihydrothiazolo[3,2-a]pyrimidine-6-carboxamide

N-(1,3-benzodioxol-5-yl)-5-oxo-2,3-dihydrothiazolo[3,2-a]pyrimidine-6-carboxamide

C14H11N3O4S (317.047)


   

5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate

5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate

C9H12N5O6P (317.0525)


   

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-(2-nitrophenyl)sulfanyloxane-3,4,5-triol

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-(2-nitrophenyl)sulfanyloxane-3,4,5-triol

C12H15NO7S (317.0569)


   

beta-citryl-L-glutamine

beta-citryl-L-glutamine

C11H13N2O9-3 (317.0621)


   

1-(6-sulfo-alpha-D-quinovosyl)glycerol

1-(6-sulfo-alpha-D-quinovosyl)glycerol

C9H17O10S- (317.0542)


   

1-Sulfoquinovosylglycerol

1-Sulfoquinovosylglycerol

C9H17O10S- (317.0542)


   

N-glycoloyl-D-glucosamine 6-phosphate

N-glycoloyl-D-glucosamine 6-phosphate

C8H16NO10P (317.0512)


   

N-glycoloyl-D-mannosamine 6-phosphate

N-glycoloyl-D-mannosamine 6-phosphate

C8H16NO10P (317.0512)


   

5-(2-Chlorophenyl)-7-(dihydroxyamino)-1,3-dihydro-1,4-benzodiazepin-2-one

5-(2-Chlorophenyl)-7-(dihydroxyamino)-1,3-dihydro-1,4-benzodiazepin-2-one

C15H12ClN3O3 (317.0567)


   

nilutamide

nilutamide

C12H10F3N3O4 (317.0623)


L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen D000970 - Antineoplastic Agents

   

7,8-dihydro-D-neopterin 2,3-cyclic phosphate

7,8-dihydro-D-neopterin 2,3-cyclic phosphate

C9H12N5O6P (317.0525)


   

N-Glycolyl-mannosamine 6-phosphate

N-Glycolyl-mannosamine 6-phosphate

C8H16NO10P (317.0512)


   

(4s,5s)-1,1-dichloro-4-ethyl-5-(4-nitrophenyl)hexan-2-one

(4s,5s)-1,1-dichloro-4-ethyl-5-(4-nitrophenyl)hexan-2-one

C14H17Cl2NO3 (317.0585)


   

1,1-dichloro-4-ethyl-5-(4-nitrophenyl)hexan-2-one

1,1-dichloro-4-ethyl-5-(4-nitrophenyl)hexan-2-one

C14H17Cl2NO3 (317.0585)


   

(4r)-2-hydroxy-4-[(s)-hydroxy(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)methyl]-1,3,2λ⁵-dioxaphospholan-2-one

(4r)-2-hydroxy-4-[(s)-hydroxy(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)methyl]-1,3,2λ⁵-dioxaphospholan-2-one

C9H12N5O6P (317.0525)


   

2-hydroxy-4-[hydroxy(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)methyl]-1,3,2λ⁵-dioxaphospholan-2-one

2-hydroxy-4-[hydroxy(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)methyl]-1,3,2λ⁵-dioxaphospholan-2-one

C9H12N5O6P (317.0525)


   

(2-{7-bromo-9h-pyrido[3,4-b]indol-1-yl}ethyl)dimethylamine

(2-{7-bromo-9h-pyrido[3,4-b]indol-1-yl}ethyl)dimethylamine

C15H16BrN3 (317.0528)